Risk of cardiovascular death in relation to blood lipid composition in male inhabitants of Tyumen: results of a 12-year prospective study


Cite item

Full Text

Abstract

Aim. To evaluate the impact of the blood levels of lipoproteins, such as total cholesterol (TC), high-density lipoproteins (HDL), triglycerides (TG), on the risk for cardiovascular death in an open Tyumen male population on the basis of a 12-year prospective follow-up study. Subjects and methods. Standard methods were used to conduct an epidemiological study of a representative sample of Tyumen males aged 25-64 years in 1996. The cardiological screening response rate was 79.5% (n=795). Eighty-five cardiovascular deaths (CVD) were registered in the male cohort during 12 years of the prospective follow-up study. The Cox proportional hazard regression model was employed to assess the relative risk (RR) of CVD. Survival rates were analyzed with the Kaplan-Meier method; the significance of lifespan differences in two groups was estimated using the log-rank test. Results. In the male cohort, a statistically significant increase in the RR of CVD occurred, starting with a TC level of ≥230 mg/dl. The lowest survival rates were noted in the males with hypercholesterolemia (HC). The statistically significant increase in the RR of CVD depending on the levels of TG was found in its 5th quintile (138 mg/dl or more). Lower survival rates were stated in the males with hypertriglyceridemia (HTG) than in those with normal blood TG levels. There were neither statistically significant results in the assessment of RR and survival rates in relation to the level of low-density lipoprotein cholesterol, no data on the effect of the level of HDL cholesterol on the RR of CVD in the males. Conclusion. According to the data of a 12-year cohort study, the open Tyumen male population was found to have a high RR of CVD in those who had TC levels ≥230 mg/dl and TG levels ≥138 mg/dl, which determined the lowest survival rates in males with HC and HTG.

About the authors

E V Akimova

Филиал НИИ кардиологии СО РАМН "Тюменский кардиологический центр"

Email: akimova@cardio.tmn.ru

E I Gakova

Филиал НИИ кардиологии СО РАМН "Тюменский кардиологический центр"

G S Pushkarev

Филиал НИИ кардиологии СО РАМН "Тюменский кардиологический центр"

V Iu Smaznov

Филиал НИИ кардиологии СО РАМН "Тюменский кардиологический центр"

M M Kaiumova

Филиал НИИ кардиологии СО РАМН "Тюменский кардиологический центр"

V V Gafarov

Межведомственная лаборатория эпидемиологии сердечно-сосудистых заболеваний СО РАМН, Новосибирск

V A Kuznetsov

Филиал НИИ кардиологии СО РАМН "Тюменский кардиологический центр"

References

  1. Gaziano T.A. Cardiovascular disease in the developing world and its cost-effective management. Circulation 2005; 112: 3547-3553.
  2. Оганов Р.Г., Масленникова Г.Я. Профилактика сердечно-сосудистых заболеваний - реальный путь улучшения демографической ситуации в России. Кардиология 2007; 1: 4-7.
  3. Yach D., Hawkes C., Gould C.L., Hofman K.J. The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA 2004; 291: 2616-2622.
  4. Yusuf S., Hawken S., Ounpuu S. et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study). Lancet 2004; 364: 937-952.
  5. Диагностика и коррекция нарушений липидного обмена с целью профилактики и лечения атеросклероза. Кардиоваск тер и проф 2009; 8: приложение 3.
  6. Реброва О.Ю. Статистический анализ медицинских данных. Применение пакета прикладных программ STATISTICA. М: Медиа Сфера; 2002.
  7. Anderson K.M., Odell P.M., Wilson P.W., Kannel W.B. Cardiovascular disease risk profiles. Am Heart J 1991; 121: 293-298.
  8. Castelli W.P., Anderson K. A population at risk. Prevalence of high cholesterol levels in hypertensive patients in the Framingham Study. Am J Med 1986; 80: 23-32.
  9. Оганов Р.Г., Погосова Г.В. Современные стратегии профилактики и лечения сердечно-сосудистых заболеваний. Кардиология 2007; 12: 4-9.
  10. Kromhout D., Menotti A., Bloemberg B. et al. Dietary saturated and trans fatty acids and cholesterol and 25-year mortality from coronary heart disease: the Seven Countries Study. Prev Med 1995; 24: 308-315.
  11. Gotto A.M. Jr. Cholesterol management in theory and practice. Circulation 1997; 96: 4224-4230.
  12. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106: 3143-3421.
  13. Dawber T.R. The Framingham Study: The Epidemiology of Atherosclerotic Disease. Cambrige, MA: Harvard Univ. Pr. 1980.
  14. Assmann G., Cullen P., Schulte H. The Munster Heart Study (PROCAM). Results of follow-up at 8 years. Eur Heart J 1998; 19: 2-11.
  15. Miller M., Cannon C.P., Murphy S.A. et al. Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial. J Am Coll Cardiol 2008; 51: 724-730.
  16. Criqui M.H., Heiss G., Cohn R., Cowan L.D. Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med 1993; 328: 1220-1225.
  17. Sarwar N., Danesh J., Eiriksdottir G. et al. Triglycerides and the risk of coronary heart disease: 10 158 incident cases among 262 525 participants in 29 western prospective studies. Circulation 2007; 115: 450-458.
  18. Акимова Е.В., Гакова Е.И., Каюмов Р.Х. и др. Некоторые компоненты метаболического синдрома у молодых мужчин открытой популяции Тюмени. Сибирский мед журн 2011; 2: 140-143.
  19. Kuller L., Meilahn N. Risk-factor for cardiovascular disease among women. Curr Opin Lipidol 1996; 7: 203-208.
  20. Assmann G., Schulte H., von Eckardstein A. Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men. Am J Cardiol 1996; 77: 1179-1184.
  21. Barter P., Gotto A.M., LaRosa J.C. et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N Engl J Med 2007; 357: 1301-1310.
  22. Castelli W.P. Cholesterol and lipids in the risk of coronary artery disease-the Framingham Heart Study. Can J Cardiol 1988; 4 (suppl A): 5A-10A.

Copyright (c) 2012 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies